Published: 17 April 2019
Author(s): Carmen Adduci, Hussam Ali, Pietro Francia, Riccardo Mantovani, Francesca Palano, Pierpaolo Lupo, Sara Foresti, Guido De Ambroggi, Riccardo Cappato
Issue: April 2019
Section: Narrative Review

The subcutaneous implantable cardioverter defibrillator (S-ICD) is a valuable alternative to the conventional trans-venous ICD (TV-ICD) for the prevention of sudden cardiac death (SCD). Prospective registries showed that the S-ICD is safe and effective in treating ventricular tachyarrhythmias in high-risk patients without pacing indications. While in earlier studies patients implanted with S-ICDs were young and mostly affected by channelopathies, contemporary S-ICD cohorts include patients with severely impaired left ventricular function and significant comorbidities.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness